Treatment of Severe Sepsis Secondary toMycobacterium Avium-Intracellularewith Recombinant Human Activated Protein C

Abstract

Treatment with rhAPC decreases the mortality rate of bacterial sepsis of abdominal origin and may confer a similar benefit in the treatment of abdominal mycobacterial sepsis.